Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY – Get Rating) have earned an average recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $274.20.
A number of research firms have issued reports on MURGY. Royal Bank of Canada began coverage on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München in a report on Wednesday, July 6th. They issued a “sector perform” rating on the stock. JPMorgan Chase & Co. lifted their price objective on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from €330.00 ($336.73) to €335.00 ($341.84) and gave the stock an “overweight” rating in a report on Monday, July 18th. Societe Generale decreased their price objective on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from €275.00 ($280.61) to €265.00 ($270.41) and set a “buy” rating on the stock in a report on Monday, July 25th. Finally, Keefe, Bruyette & Woods raised Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from an “underperform” rating to an “outperform” rating in a report on Thursday, August 25th.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Performance
Shares of OTCMKTS MURGY opened at $24.13 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.24 and a current ratio of 0.24. The firm has a market cap of $33.81 billion, a price-to-earnings ratio of 11.49, a P/E/G ratio of 0.56 and a beta of 0.95. The business’s 50-day simple moving average is $23.09 and its 200-day simple moving average is $24.56. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 52 week low of $21.21 and a 52 week high of $31.95.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY – Get Rating) last issued its quarterly earnings data on Tuesday, August 9th. The financial services provider reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.17. The business had revenue of $18.30 billion for the quarter. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a return on equity of 7.99% and a net margin of 3.90%. As a group, equities research analysts expect that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 2.44 earnings per share for the current fiscal year.
About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
(Get Rating)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through five segments: Life and Health Reinsurance; Property-Casualty Reinsurance; ERGO Life and Health Germany; ERGO Property-Casualty Germany; and ERGO International.
Further Reading
- Get a free copy of the StockNews.com research report on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn’t on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
